Govt panel recommends Corbevax for 12-18 group

An expert panel of India’s central drug authority on Monday recommended granting restricted emergency use authorisation to Biological E’s COVID-19 vaccine, Corbevax, for age group 12 to 18 years.

migrator

Published:15th Feb, 2022 at 5:00 AM

New Delhi

An expert panel of India’s central drug authority on Monday recommended granting restricted emergency use authorisation to Biological E’s COVID-19 vaccine, Corbevax, for age group 12 to 18 years subject to certain conditions, official sources said. The Drugs Controller General Of India has already approved Corbevax, which is India’s first indigenously developed RBD protein sub-unit vaccine against COVID-19, for restricted use in adults.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

Govt panel recommends Corbevax for 12-18 group

An expert panel of India’s central drug authority on Monday recommended granting restricted emergency use authorisation to Biological E’s COVID-19 vaccine, Corbevax, for age group 12 to 18 years.

Also Read

24 hours enough to line up allies: BJP's Nainar Nagenthran on OPS, TTV

Confident of poaching AIADMK leaders, Sengottaiyan silent on OPS

Hoax bomb threat to Bangladesh deputy high commission in Chennai

CPI slams EC for notice to 10L voters

Chennai police launch hunt for rash driving 'Santa Claus'